SlideShare a Scribd company logo
1 of 28
 17 maart 2010 by WimSmit 12-03-2010 1 In Vitro Diagnostiek “Bloedserieus”
12-03-2010 2
12-03-2010 3 About us!
Mission Future Diagnostics strives to become the best developer of high-quality and innovative diagnostic tests, today, and in the future seen in the eyes of our customers and our employees.
Vision Future Diagnostics strives to become the market leader in test development for third parties.  We want to become the independent partner of the top 25 IVD companies for their test development.  We would like to achieve this position by translating new technologies and novel ‘Intellectual Properties’ to the development of innovative tests with the shortest possible development time at the lowest possible costs.
Facts Activities started May 01st, 1997  Privately owned company, MBO completed Oct 5th, 2007  6 employees in1997 / current number of employees is 60  Current number of projects is 34 / 40 available slots  19 Scientists with University degree  2 facilities: Nieuweweg and Edisonstraat  Received ISO-9001/EN46001 certification Oct 97  Received ISO 9001/2000 and ISO 13485 Oct 2003 In compliance with the In Vitro Diagnostics Directive(IVDD) and the FDA’s Quality System Regulation (QSR) for medical devices 12-03-2010 6
Our Facilities 12-03-2010 7
12-03-2010 8 Assays for > different analytes!
Assays for > different analytes! 12-03-2010 9
12-03-2010 10 Assays for > different analytes!
12-03-2010 11 Customers Confidential
12-03-2010 12 Customers
12-03-2010 13 Experience on automated platforms
12-03-2010 14 Area’s of major interest Development of diagnostic tests on different automated platforms. Prototyping of POC tests for diagnoses in the areas of surgery, transplantation, stroke, minor and severe head injury. Research on new, innovative and sensitive technologies in the area of “near to patient testing”.
12-03-2010 15 Trends, Opportunities & Threats in the Healthcare! Source: TriMark Publications
Trends in healthcare Less than 5% of the $3 trillion spent each year on the health care worldwide is for clinical laboratory services. Considering that nearly 70% of health care decisions are based on critical diagnostics information, biomedical testing represents a significant source of value in healthcare. Source: TriMark Publications
12-03-2010 17
12-03-2010 18 Trends in healthcare ,[object Object]
Reducing healthcare costs by increasing use IVD tests.
Technological development, new tests and markers
Point of Care testing outside the laboratory directly to the patient, ambulance, first aid or doctor.
Further automation of instruments and laboratories.Source: TriMark Publications
12-03-2010 19 Point Of Care???
POC opens the door for change for the  In Vitro Diagnostics & Healthcare. The purpose of point of care testing is the provision of a test result at the most appropriate point in time; enabling a decision on action to be taken that will result in an improved health outcome, without incurring additional costs. There is a need to develop point of care platforms that are able to perform a wide menu of complex in vitro diagnostic tests from minute samples, with the accuracy associated with laboratory systems. Source: TriMark Publications 20
POC opens the door for change for the  In Vitro Diagnostics & Healthcare. For blood testing, it offers the option of moving some complex immunoassays out of the lab, saving more lives by speeding up the tests needed to detect life-threatening conditions. There is already a trend away from centralised treatment and testing to one which delivers care in a more patient-friendly way. We are convinced that improving point-of-care testing in acute settings in the hospital and at home is in the best interest of patients. Source: TriMark Publications 21
12-03-2010 22
12-03-2010 23
12-03-2010 24

More Related Content

What's hot

SPOTLIGHT ON MIGS
SPOTLIGHT ON MIGSSPOTLIGHT ON MIGS
SPOTLIGHT ON MIGSHealthegy
 
Posterior Segment Company Showcase - Notal vision
Posterior Segment Company Showcase - Notal visionPosterior Segment Company Showcase - Notal vision
Posterior Segment Company Showcase - Notal visionHealthegy
 
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언Yoon Sup Choi
 
Ophthalmic Innovation 2016 - "A View From The AAO"
Ophthalmic Innovation 2016 - "A View From The AAO"Ophthalmic Innovation 2016 - "A View From The AAO"
Ophthalmic Innovation 2016 - "A View From The AAO"Healthegy
 
Medical retina functionality, OpenEyes demonstration, Dr Tim Elliott, OpenEye...
Medical retina functionality, OpenEyes demonstration, Dr Tim Elliott, OpenEye...Medical retina functionality, OpenEyes demonstration, Dr Tim Elliott, OpenEye...
Medical retina functionality, OpenEyes demonstration, Dr Tim Elliott, OpenEye...mfolkard
 
Eric Donnenfeld, MD Presentation
Eric Donnenfeld, MD PresentationEric Donnenfeld, MD Presentation
Eric Donnenfeld, MD PresentationHealthegy
 
TTe - Medical Brochure 2013
TTe - Medical Brochure 2013TTe - Medical Brochure 2013
TTe - Medical Brochure 2013Siddharth Gupta
 
Posterior Segment Company Showcase - PanOptica
Posterior Segment Company Showcase - PanOpticaPosterior Segment Company Showcase - PanOptica
Posterior Segment Company Showcase - PanOpticaHealthegy
 
Health Valley 2014: Jack Schalken
Health Valley 2014: Jack SchalkenHealth Valley 2014: Jack Schalken
Health Valley 2014: Jack SchalkenHealth Valley
 
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...April Bright
 
Why Data Science Matters and How It Enables Impactful Health Outcomes - Webinar
Why Data Science Matters and How It Enables Impactful Health Outcomes - WebinarWhy Data Science Matters and How It Enables Impactful Health Outcomes - Webinar
Why Data Science Matters and How It Enables Impactful Health Outcomes - WebinarValencell, Inc
 
Ophthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate PharmaOphthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate PharmaHealthegy
 
Professor James Ferguson
Professor James FergusonProfessor James Ferguson
Professor James FergusonInvestnet
 
Public Device & Biopharma Ophthalmology Company Showcase - QLT
Public Device & Biopharma Ophthalmology Company Showcase - QLTPublic Device & Biopharma Ophthalmology Company Showcase - QLT
Public Device & Biopharma Ophthalmology Company Showcase - QLTHealthegy
 
Webinar: Calibration-free blood pressure monitoring using biometric earbuds
Webinar: Calibration-free blood pressure monitoring using biometric earbudsWebinar: Calibration-free blood pressure monitoring using biometric earbuds
Webinar: Calibration-free blood pressure monitoring using biometric earbudsValencell, Inc
 
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, InvestmentPoint of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, InvestmentBruce Carlson
 
SPNC/MSC 22015 Case Study
SPNC/MSC 22015 Case Study SPNC/MSC 22015 Case Study
SPNC/MSC 22015 Case Study Jason Gwilliam
 

What's hot (20)

SPOTLIGHT ON MIGS
SPOTLIGHT ON MIGSSPOTLIGHT ON MIGS
SPOTLIGHT ON MIGS
 
Posterior Segment Company Showcase - Notal vision
Posterior Segment Company Showcase - Notal visionPosterior Segment Company Showcase - Notal vision
Posterior Segment Company Showcase - Notal vision
 
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
 
Ophthalmic Innovation 2016 - "A View From The AAO"
Ophthalmic Innovation 2016 - "A View From The AAO"Ophthalmic Innovation 2016 - "A View From The AAO"
Ophthalmic Innovation 2016 - "A View From The AAO"
 
Medical retina functionality, OpenEyes demonstration, Dr Tim Elliott, OpenEye...
Medical retina functionality, OpenEyes demonstration, Dr Tim Elliott, OpenEye...Medical retina functionality, OpenEyes demonstration, Dr Tim Elliott, OpenEye...
Medical retina functionality, OpenEyes demonstration, Dr Tim Elliott, OpenEye...
 
Avedro
AvedroAvedro
Avedro
 
Eric Donnenfeld, MD Presentation
Eric Donnenfeld, MD PresentationEric Donnenfeld, MD Presentation
Eric Donnenfeld, MD Presentation
 
TTe - Medical Brochure 2013
TTe - Medical Brochure 2013TTe - Medical Brochure 2013
TTe - Medical Brochure 2013
 
Project Luckie
Project LuckieProject Luckie
Project Luckie
 
Posterior Segment Company Showcase - PanOptica
Posterior Segment Company Showcase - PanOpticaPosterior Segment Company Showcase - PanOptica
Posterior Segment Company Showcase - PanOptica
 
Health Valley 2014: Jack Schalken
Health Valley 2014: Jack SchalkenHealth Valley 2014: Jack Schalken
Health Valley 2014: Jack Schalken
 
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
 
Why Data Science Matters and How It Enables Impactful Health Outcomes - Webinar
Why Data Science Matters and How It Enables Impactful Health Outcomes - WebinarWhy Data Science Matters and How It Enables Impactful Health Outcomes - Webinar
Why Data Science Matters and How It Enables Impactful Health Outcomes - Webinar
 
Ophthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate PharmaOphthalmology Innovation Showcase 1 - EyeGate Pharma
Ophthalmology Innovation Showcase 1 - EyeGate Pharma
 
Allegro
AllegroAllegro
Allegro
 
Professor James Ferguson
Professor James FergusonProfessor James Ferguson
Professor James Ferguson
 
Public Device & Biopharma Ophthalmology Company Showcase - QLT
Public Device & Biopharma Ophthalmology Company Showcase - QLTPublic Device & Biopharma Ophthalmology Company Showcase - QLT
Public Device & Biopharma Ophthalmology Company Showcase - QLT
 
Webinar: Calibration-free blood pressure monitoring using biometric earbuds
Webinar: Calibration-free blood pressure monitoring using biometric earbudsWebinar: Calibration-free blood pressure monitoring using biometric earbuds
Webinar: Calibration-free blood pressure monitoring using biometric earbuds
 
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, InvestmentPoint of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
 
SPNC/MSC 22015 Case Study
SPNC/MSC 22015 Case Study SPNC/MSC 22015 Case Study
SPNC/MSC 22015 Case Study
 

Similar to Future Diagnostics, In Vitro Diagnostiek "Bloedserieus"

Knowledge Engineering in Oncology
Knowledge Engineering in OncologyKnowledge Engineering in Oncology
Knowledge Engineering in OncologyMAASTRO clinic
 
10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdfinsightscare
 
EuroBioForum 2013 - Day 2 | Frank Molina
 EuroBioForum 2013 - Day 2 | Frank Molina EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
 
5 Best Companies in Digital Pathology Market, March 2023
5 Best Companies in Digital Pathology Market, March 20235 Best Companies in Digital Pathology Market, March 2023
5 Best Companies in Digital Pathology Market, March 2023insightscare
 
Biosensor for Early Detection of Breast Cancer - LIKA-CESAR Partnership
Biosensor for Early Detection of Breast Cancer - LIKA-CESAR PartnershipBiosensor for Early Detection of Breast Cancer - LIKA-CESAR Partnership
Biosensor for Early Detection of Breast Cancer - LIKA-CESAR PartnershipCESAR
 
LECTUREThe Impact of Technology on Clinical and IT SystemsIn.docx
LECTUREThe Impact of Technology on Clinical and IT SystemsIn.docxLECTUREThe Impact of Technology on Clinical and IT SystemsIn.docx
LECTUREThe Impact of Technology on Clinical and IT SystemsIn.docxsmile790243
 
Apport du Big Data pour la médecine personnalisée
Apport du Big Data pour la médecine personnaliséeApport du Big Data pour la médecine personnalisée
Apport du Big Data pour la médecine personnaliséeTELECOM-PARISTECH-SANTE
 
Intel telecom paris tech 20160616
Intel   telecom paris tech 20160616Intel   telecom paris tech 20160616
Intel telecom paris tech 20160616Alain Tassy
 
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016Pistoia Alliance
 
The Impact of Technology on Clinical and IT SystemsIntroduction.docx
The Impact of Technology on Clinical and IT SystemsIntroduction.docxThe Impact of Technology on Clinical and IT SystemsIntroduction.docx
The Impact of Technology on Clinical and IT SystemsIntroduction.docxoreo10
 
Five innovative technologies for health
Five innovative technologies for healthFive innovative technologies for health
Five innovative technologies for healthMpower Medical Inc
 
Thomas Willkens-El impacto de las ciencias ómicas en la medicina, la nutrició...
Thomas Willkens-El impacto de las ciencias ómicas en la medicina, la nutrició...Thomas Willkens-El impacto de las ciencias ómicas en la medicina, la nutrició...
Thomas Willkens-El impacto de las ciencias ómicas en la medicina, la nutrició...Fundación Ramón Areces
 
Article IVD March 2006
Article IVD March 2006Article IVD March 2006
Article IVD March 2006Fabrice Sultan
 
IoE in Clinical Trials
IoE in Clinical TrialsIoE in Clinical Trials
IoE in Clinical TrialsCRF Health
 
SW Biotechnology pack
SW Biotechnology packSW Biotechnology pack
SW Biotechnology packRichard Male
 
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...PharmaLedger
 
Point of Care - EOS Additive Manufacturing with Selective Laser Sintering - ...
Point of Care  - EOS Additive Manufacturing with Selective Laser Sintering - ...Point of Care  - EOS Additive Manufacturing with Selective Laser Sintering - ...
Point of Care - EOS Additive Manufacturing with Selective Laser Sintering - ...Machine Tool Systems Inc.
 
Predictive in vitro & in silico Methods for Precision Medicine- Robert G. Hun...
Predictive in vitro & in silico Methods for Precision Medicine- Robert G. Hun...Predictive in vitro & in silico Methods for Precision Medicine- Robert G. Hun...
Predictive in vitro & in silico Methods for Precision Medicine- Robert G. Hun...RobertGHunter
 
Clinical Trials In 2023.pdf
Clinical Trials In 2023.pdfClinical Trials In 2023.pdf
Clinical Trials In 2023.pdfDIBSTechnology
 
So, My FitBit is Clinical Trial Grade Right?
So, My FitBit is Clinical Trial Grade Right?So, My FitBit is Clinical Trial Grade Right?
So, My FitBit is Clinical Trial Grade Right?PAREXEL International
 

Similar to Future Diagnostics, In Vitro Diagnostiek "Bloedserieus" (20)

Knowledge Engineering in Oncology
Knowledge Engineering in OncologyKnowledge Engineering in Oncology
Knowledge Engineering in Oncology
 
10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf10 Most Innovative CRO’s To Watch In 2022.pdf
10 Most Innovative CRO’s To Watch In 2022.pdf
 
EuroBioForum 2013 - Day 2 | Frank Molina
 EuroBioForum 2013 - Day 2 | Frank Molina EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank Molina
 
5 Best Companies in Digital Pathology Market, March 2023
5 Best Companies in Digital Pathology Market, March 20235 Best Companies in Digital Pathology Market, March 2023
5 Best Companies in Digital Pathology Market, March 2023
 
Biosensor for Early Detection of Breast Cancer - LIKA-CESAR Partnership
Biosensor for Early Detection of Breast Cancer - LIKA-CESAR PartnershipBiosensor for Early Detection of Breast Cancer - LIKA-CESAR Partnership
Biosensor for Early Detection of Breast Cancer - LIKA-CESAR Partnership
 
LECTUREThe Impact of Technology on Clinical and IT SystemsIn.docx
LECTUREThe Impact of Technology on Clinical and IT SystemsIn.docxLECTUREThe Impact of Technology on Clinical and IT SystemsIn.docx
LECTUREThe Impact of Technology on Clinical and IT SystemsIn.docx
 
Apport du Big Data pour la médecine personnalisée
Apport du Big Data pour la médecine personnaliséeApport du Big Data pour la médecine personnalisée
Apport du Big Data pour la médecine personnalisée
 
Intel telecom paris tech 20160616
Intel   telecom paris tech 20160616Intel   telecom paris tech 20160616
Intel telecom paris tech 20160616
 
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
Pistoia Alliance Debates: Clinical trials and wearables, 21st Jan 2016
 
The Impact of Technology on Clinical and IT SystemsIntroduction.docx
The Impact of Technology on Clinical and IT SystemsIntroduction.docxThe Impact of Technology on Clinical and IT SystemsIntroduction.docx
The Impact of Technology on Clinical and IT SystemsIntroduction.docx
 
Five innovative technologies for health
Five innovative technologies for healthFive innovative technologies for health
Five innovative technologies for health
 
Thomas Willkens-El impacto de las ciencias ómicas en la medicina, la nutrició...
Thomas Willkens-El impacto de las ciencias ómicas en la medicina, la nutrició...Thomas Willkens-El impacto de las ciencias ómicas en la medicina, la nutrició...
Thomas Willkens-El impacto de las ciencias ómicas en la medicina, la nutrició...
 
Article IVD March 2006
Article IVD March 2006Article IVD March 2006
Article IVD March 2006
 
IoE in Clinical Trials
IoE in Clinical TrialsIoE in Clinical Trials
IoE in Clinical Trials
 
SW Biotechnology pack
SW Biotechnology packSW Biotechnology pack
SW Biotechnology pack
 
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...
 
Point of Care - EOS Additive Manufacturing with Selective Laser Sintering - ...
Point of Care  - EOS Additive Manufacturing with Selective Laser Sintering - ...Point of Care  - EOS Additive Manufacturing with Selective Laser Sintering - ...
Point of Care - EOS Additive Manufacturing with Selective Laser Sintering - ...
 
Predictive in vitro & in silico Methods for Precision Medicine- Robert G. Hun...
Predictive in vitro & in silico Methods for Precision Medicine- Robert G. Hun...Predictive in vitro & in silico Methods for Precision Medicine- Robert G. Hun...
Predictive in vitro & in silico Methods for Precision Medicine- Robert G. Hun...
 
Clinical Trials In 2023.pdf
Clinical Trials In 2023.pdfClinical Trials In 2023.pdf
Clinical Trials In 2023.pdf
 
So, My FitBit is Clinical Trial Grade Right?
So, My FitBit is Clinical Trial Grade Right?So, My FitBit is Clinical Trial Grade Right?
So, My FitBit is Clinical Trial Grade Right?
 

More from Health Valley

Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014 Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014 Health Valley
 
HV Cafe Road2Germany Minddistrict
HV Cafe Road2Germany MinddistrictHV Cafe Road2Germany Minddistrict
HV Cafe Road2Germany MinddistrictHealth Valley
 
HV Cafe Road2Germany KvK
HV Cafe Road2Germany KvKHV Cafe Road2Germany KvK
HV Cafe Road2Germany KvKHealth Valley
 
HV Cafe Road2Germany
HV Cafe Road2Germany HV Cafe Road2Germany
HV Cafe Road2Germany Health Valley
 
HVE 2014 Pecha Kucha: Pieter van Gorp
HVE 2014 Pecha Kucha: Pieter van GorpHVE 2014 Pecha Kucha: Pieter van Gorp
HVE 2014 Pecha Kucha: Pieter van GorpHealth Valley
 
HVE 2014 Pecha Kucha: Paul de Jonge
HVE 2014 Pecha Kucha: Paul de JongeHVE 2014 Pecha Kucha: Paul de Jonge
HVE 2014 Pecha Kucha: Paul de JongeHealth Valley
 
HVE 2014 Pecha Kucha: Maarten Merckx
HVE 2014 Pecha Kucha: Maarten MerckxHVE 2014 Pecha Kucha: Maarten Merckx
HVE 2014 Pecha Kucha: Maarten MerckxHealth Valley
 
HVE 2014 Pecha Kucha: Jeroen Hasselaar
HVE 2014 Pecha Kucha: Jeroen HasselaarHVE 2014 Pecha Kucha: Jeroen Hasselaar
HVE 2014 Pecha Kucha: Jeroen HasselaarHealth Valley
 
HVE 2014 Pecha Kucha: Charlotte van der Vos
HVE 2014 Pecha Kucha: Charlotte van der VosHVE 2014 Pecha Kucha: Charlotte van der Vos
HVE 2014 Pecha Kucha: Charlotte van der VosHealth Valley
 
HVE 2014 Pecha Kucha: Arieke Janse
HVE 2014 Pecha Kucha: Arieke JanseHVE 2014 Pecha Kucha: Arieke Janse
HVE 2014 Pecha Kucha: Arieke JanseHealth Valley
 
HVE 2014 Pecha Kucha: Stefan Hummelink
HVE 2014 Pecha Kucha: Stefan HummelinkHVE 2014 Pecha Kucha: Stefan Hummelink
HVE 2014 Pecha Kucha: Stefan HummelinkHealth Valley
 
Health Valley Event 2014: Anja Garritsen, Innatoss
Health Valley Event 2014: Anja Garritsen, InnatossHealth Valley Event 2014: Anja Garritsen, Innatoss
Health Valley Event 2014: Anja Garritsen, InnatossHealth Valley
 
Health Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
Health Valley Event 2014: Jan Raaijmakers, Universiteit UtrechtHealth Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
Health Valley Event 2014: Jan Raaijmakers, Universiteit UtrechtHealth Valley
 
Health Valley Event 2014: Alain van Gool, Radboudumc
Health Valley Event 2014: Alain van Gool, RadboudumcHealth Valley Event 2014: Alain van Gool, Radboudumc
Health Valley Event 2014: Alain van Gool, RadboudumcHealth Valley
 
Health Valley Event 2014: Han van Krieken, Radboudumc
Health Valley Event 2014: Han van Krieken, RadboudumcHealth Valley Event 2014: Han van Krieken, Radboudumc
Health Valley Event 2014: Han van Krieken, RadboudumcHealth Valley
 
Health Valley Event 2014: Chiel Bos, CPZ
Health Valley Event 2014: Chiel Bos, CPZHealth Valley Event 2014: Chiel Bos, CPZ
Health Valley Event 2014: Chiel Bos, CPZHealth Valley
 
Health Valley 2014: Dick Herfst
Health Valley 2014: Dick HerfstHealth Valley 2014: Dick Herfst
Health Valley 2014: Dick HerfstHealth Valley
 
Health Valley Event 2014: Co Politiek, Aimpact
Health Valley Event 2014: Co Politiek, Aimpact Health Valley Event 2014: Co Politiek, Aimpact
Health Valley Event 2014: Co Politiek, Aimpact Health Valley
 
Health Valley Event 2014: Marieke Hettinga, Windesheim
Health Valley Event 2014: Marieke Hettinga, WindesheimHealth Valley Event 2014: Marieke Hettinga, Windesheim
Health Valley Event 2014: Marieke Hettinga, WindesheimHealth Valley
 
Workshop Co-creatie in de zorg: Embedded Field labs
Workshop Co-creatie in de zorg: Embedded Field labsWorkshop Co-creatie in de zorg: Embedded Field labs
Workshop Co-creatie in de zorg: Embedded Field labsHealth Valley
 

More from Health Valley (20)

Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014 Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
 
HV Cafe Road2Germany Minddistrict
HV Cafe Road2Germany MinddistrictHV Cafe Road2Germany Minddistrict
HV Cafe Road2Germany Minddistrict
 
HV Cafe Road2Germany KvK
HV Cafe Road2Germany KvKHV Cafe Road2Germany KvK
HV Cafe Road2Germany KvK
 
HV Cafe Road2Germany
HV Cafe Road2Germany HV Cafe Road2Germany
HV Cafe Road2Germany
 
HVE 2014 Pecha Kucha: Pieter van Gorp
HVE 2014 Pecha Kucha: Pieter van GorpHVE 2014 Pecha Kucha: Pieter van Gorp
HVE 2014 Pecha Kucha: Pieter van Gorp
 
HVE 2014 Pecha Kucha: Paul de Jonge
HVE 2014 Pecha Kucha: Paul de JongeHVE 2014 Pecha Kucha: Paul de Jonge
HVE 2014 Pecha Kucha: Paul de Jonge
 
HVE 2014 Pecha Kucha: Maarten Merckx
HVE 2014 Pecha Kucha: Maarten MerckxHVE 2014 Pecha Kucha: Maarten Merckx
HVE 2014 Pecha Kucha: Maarten Merckx
 
HVE 2014 Pecha Kucha: Jeroen Hasselaar
HVE 2014 Pecha Kucha: Jeroen HasselaarHVE 2014 Pecha Kucha: Jeroen Hasselaar
HVE 2014 Pecha Kucha: Jeroen Hasselaar
 
HVE 2014 Pecha Kucha: Charlotte van der Vos
HVE 2014 Pecha Kucha: Charlotte van der VosHVE 2014 Pecha Kucha: Charlotte van der Vos
HVE 2014 Pecha Kucha: Charlotte van der Vos
 
HVE 2014 Pecha Kucha: Arieke Janse
HVE 2014 Pecha Kucha: Arieke JanseHVE 2014 Pecha Kucha: Arieke Janse
HVE 2014 Pecha Kucha: Arieke Janse
 
HVE 2014 Pecha Kucha: Stefan Hummelink
HVE 2014 Pecha Kucha: Stefan HummelinkHVE 2014 Pecha Kucha: Stefan Hummelink
HVE 2014 Pecha Kucha: Stefan Hummelink
 
Health Valley Event 2014: Anja Garritsen, Innatoss
Health Valley Event 2014: Anja Garritsen, InnatossHealth Valley Event 2014: Anja Garritsen, Innatoss
Health Valley Event 2014: Anja Garritsen, Innatoss
 
Health Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
Health Valley Event 2014: Jan Raaijmakers, Universiteit UtrechtHealth Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
Health Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
 
Health Valley Event 2014: Alain van Gool, Radboudumc
Health Valley Event 2014: Alain van Gool, RadboudumcHealth Valley Event 2014: Alain van Gool, Radboudumc
Health Valley Event 2014: Alain van Gool, Radboudumc
 
Health Valley Event 2014: Han van Krieken, Radboudumc
Health Valley Event 2014: Han van Krieken, RadboudumcHealth Valley Event 2014: Han van Krieken, Radboudumc
Health Valley Event 2014: Han van Krieken, Radboudumc
 
Health Valley Event 2014: Chiel Bos, CPZ
Health Valley Event 2014: Chiel Bos, CPZHealth Valley Event 2014: Chiel Bos, CPZ
Health Valley Event 2014: Chiel Bos, CPZ
 
Health Valley 2014: Dick Herfst
Health Valley 2014: Dick HerfstHealth Valley 2014: Dick Herfst
Health Valley 2014: Dick Herfst
 
Health Valley Event 2014: Co Politiek, Aimpact
Health Valley Event 2014: Co Politiek, Aimpact Health Valley Event 2014: Co Politiek, Aimpact
Health Valley Event 2014: Co Politiek, Aimpact
 
Health Valley Event 2014: Marieke Hettinga, Windesheim
Health Valley Event 2014: Marieke Hettinga, WindesheimHealth Valley Event 2014: Marieke Hettinga, Windesheim
Health Valley Event 2014: Marieke Hettinga, Windesheim
 
Workshop Co-creatie in de zorg: Embedded Field labs
Workshop Co-creatie in de zorg: Embedded Field labsWorkshop Co-creatie in de zorg: Embedded Field labs
Workshop Co-creatie in de zorg: Embedded Field labs
 

Future Diagnostics, In Vitro Diagnostiek "Bloedserieus"

  • 1. 17 maart 2010 by WimSmit 12-03-2010 1 In Vitro Diagnostiek “Bloedserieus”
  • 4. Mission Future Diagnostics strives to become the best developer of high-quality and innovative diagnostic tests, today, and in the future seen in the eyes of our customers and our employees.
  • 5. Vision Future Diagnostics strives to become the market leader in test development for third parties. We want to become the independent partner of the top 25 IVD companies for their test development. We would like to achieve this position by translating new technologies and novel ‘Intellectual Properties’ to the development of innovative tests with the shortest possible development time at the lowest possible costs.
  • 6. Facts Activities started May 01st, 1997 Privately owned company, MBO completed Oct 5th, 2007 6 employees in1997 / current number of employees is 60 Current number of projects is 34 / 40 available slots 19 Scientists with University degree 2 facilities: Nieuweweg and Edisonstraat Received ISO-9001/EN46001 certification Oct 97 Received ISO 9001/2000 and ISO 13485 Oct 2003 In compliance with the In Vitro Diagnostics Directive(IVDD) and the FDA’s Quality System Regulation (QSR) for medical devices 12-03-2010 6
  • 8. 12-03-2010 8 Assays for > different analytes!
  • 9. Assays for > different analytes! 12-03-2010 9
  • 10. 12-03-2010 10 Assays for > different analytes!
  • 11. 12-03-2010 11 Customers Confidential
  • 13. 12-03-2010 13 Experience on automated platforms
  • 14. 12-03-2010 14 Area’s of major interest Development of diagnostic tests on different automated platforms. Prototyping of POC tests for diagnoses in the areas of surgery, transplantation, stroke, minor and severe head injury. Research on new, innovative and sensitive technologies in the area of “near to patient testing”.
  • 15. 12-03-2010 15 Trends, Opportunities & Threats in the Healthcare! Source: TriMark Publications
  • 16. Trends in healthcare Less than 5% of the $3 trillion spent each year on the health care worldwide is for clinical laboratory services. Considering that nearly 70% of health care decisions are based on critical diagnostics information, biomedical testing represents a significant source of value in healthcare. Source: TriMark Publications
  • 18.
  • 19. Reducing healthcare costs by increasing use IVD tests.
  • 20. Technological development, new tests and markers
  • 21. Point of Care testing outside the laboratory directly to the patient, ambulance, first aid or doctor.
  • 22. Further automation of instruments and laboratories.Source: TriMark Publications
  • 23. 12-03-2010 19 Point Of Care???
  • 24. POC opens the door for change for the In Vitro Diagnostics & Healthcare. The purpose of point of care testing is the provision of a test result at the most appropriate point in time; enabling a decision on action to be taken that will result in an improved health outcome, without incurring additional costs. There is a need to develop point of care platforms that are able to perform a wide menu of complex in vitro diagnostic tests from minute samples, with the accuracy associated with laboratory systems. Source: TriMark Publications 20
  • 25. POC opens the door for change for the In Vitro Diagnostics & Healthcare. For blood testing, it offers the option of moving some complex immunoassays out of the lab, saving more lives by speeding up the tests needed to detect life-threatening conditions. There is already a trend away from centralised treatment and testing to one which delivers care in a more patient-friendly way. We are convinced that improving point-of-care testing in acute settings in the hospital and at home is in the best interest of patients. Source: TriMark Publications 21
  • 29.
  • 30. Ease of use (potentially applicable for home testing, GP & specialist office)
  • 31. Multi-analyte (several analytes can be measured simultaneously)
  • 33.
  • 34. 27 Philips Future Diagnostics
  • 35. 12-03-2010 28 Thank you Questions?